SCIESCOPUSQ1
ESMO Open
ELSEVIER, Netherlands
ESMO Open is an academic journal published by ELSEVIER (Netherlands). Identifiers: eISSN 2059-7029. Indexed in SCIE, SCOPUS. Metrics: JIF 8.3, CiteScore 12.4, SJR 3.582, SNIP 1.98. Subject areas: ONCOLOGY. tlooto lists 9,964 papers from this journal.
CiteScore
12.40
Scopus の引用指標
SJR
3.582
SCImago 順位
SNIP
1.98
出典で正規化した影響度
パーセンタイル順位
-
JIF のパーセンタイル順位
ジャーナルプロフィール
- ISSN
- -
- eISSN
- 2059-7029
- 略語
- ESMO OPEN
- 出版社
- ELSEVIER
- 国
- Netherlands
Web of Science の分野
SCIEONCOLOGY
Scopus ASJC の分野
1306 Cancer Research2730 Oncology
キーワード
Oncology
Papers in this journal
Recent papers
- 38eP AI-based identification of TKI-sensitive driver mutations using routine histopathology in lung adenocarcinoma
2026
- 438P Chemoimmunotherapy versus chemotherapy for extensive-stage small cell lung cancer: A retrospective real-world study of 904 patients
2026
- 624P Longitudinal medical cannabis use patterns and patient characteristics among Florida Medicare beneficiaries with incident breast cancer
2026
- 43P First-line clinical outcomes of single versus compound EGFR PACC mutations in advanced NSCLC: An international multicentre study
2026
- 304P Sintilimab consolidation therapy following concurrent chemoradiotherapy in unresectable stage III NSCLC: Primary results from the prospective CONSIST trial
2026
Most cited papers
- Multiple primary tumours: challenges and approaches, a review
2017 · 545 citations
- NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
2016 · 525 citations
- Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
2020 · 457 citations
- Mechanisms of resistance to EGFR-targeted drugs: lung cancer
2016 · 410 citations
- Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
2021 · 406 citations